Automated Network Analysis Identifies Core Pathways in Glioblastoma

Background Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumor in humans and the first cancer with comprehensive genomic profiles mapped by The Cancer Genome Atlas (TCGA) project. A central challenge in large-scale genome projects, such as the TCGA GBM project, is the ability to distinguish cancer-causing “driver” mutations from passively selected “passenger” mutations. Principal Findings In contrast to a purely frequency based approach to identifying driver mutations in cancer, we propose an automated network-based approach for identifying candidate oncogenic processes and driver genes. The approach is based on the hypothesis that cellular networks contain functional modules, and that tumors target specific modules critical to their growth. Key elements in the approach include combined analysis of sequence mutations and DNA copy number alterations; use of a unified molecular interaction network consisting of both protein-protein interactions and signaling pathways; and identification and statistical assessment of network modules, i.e. cohesive groups of genes of interest with a higher density of interactions within groups than between groups. Conclusions We confirm and extend the observation that GBM alterations tend to occur within specific functional modules, in spite of considerable patient-to-patient variation, and that two of the largest modules involve signaling via p53, Rb, PI3K and receptor protein kinases. We also identify new candidate drivers in GBM, including AGAP2/CENTG1, a putative oncogene and an activator of the PI3K pathway; and, three additional significantly altered modules, including one involved in microtubule organization. To facilitate the application of our network-based approach to additional cancer types, we make the method freely available as part of a software tool called NetBox.

[1]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[2]  C. James,et al.  Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.

[3]  P. Meltzer,et al.  Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. , 1994, Cancer research.

[4]  D. Louis,et al.  The retinoblastoma gene is involved in malignant progression of astrocytomas , 1994, Annals of neurology.

[5]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[6]  W Arap,et al.  Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. , 1997, Cancer research.

[7]  D. Kwiatkowski,et al.  Advillin (p92): a new member of the gelsolin/villin family of actin regulatory proteins. , 1998, Journal of cell science.

[8]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[9]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[10]  E. Holland,et al.  Glioblastoma multiforme: the terminator. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Alfonso Valencia,et al.  Can Bibliographic Pointers for Known Biological Data Be Found Automatically? Protein Interactions as a Case Study , 2001, Comparative and functional genomics.

[12]  K. Sneppen,et al.  Specificity and Stability in Topology of Protein Networks , 2002, Science.

[13]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[15]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[16]  Paul S Mischel,et al.  Targeted Molecular Therapy of GBM , 2003, Brain pathology.

[17]  L. Mirny,et al.  Protein complexes and functional modules in molecular networks , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[19]  Alexander Rives,et al.  Modular organization of cellular networks , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Anton J. Enright,et al.  Detection of functional modules from protein interaction networks , 2003, Proteins.

[21]  Jee-Yin Ahn,et al.  PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Guimerà,et al.  Modularity from fluctuations in random graphs and complex networks. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.

[23]  Igor Jurisica,et al.  Functional topology in a network of protein interactions , 2004, Bioinform..

[24]  M. Newman Coauthorship networks and patterns of scientific collaboration , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M E J Newman,et al.  Finding and evaluating community structure in networks. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[26]  G. Reifenberger,et al.  Genetic alteration and expression of the phosphoinositol‐3‐kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas , 2005, Neuropathology and applied neurobiology.

[27]  Susumu Goto,et al.  Extraction of phylogenetic network modules from the metabolic network , 2006, BMC Bioinformatics.

[28]  R. Guimerà,et al.  Functional cartography of complex metabolic networks , 2005, Nature.

[29]  A. Longatto-Filho,et al.  Molecular Characterization of PDGFR-α/PDGF-A and c-KIT/SCF in Gliosarcomas , 2005, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[30]  Changning Liu,et al.  Integrated analysis of multiple data sources reveals modular structure of biological networks. , 2006, Biochemical and biophysical research communications.

[31]  Jingchun Chen,et al.  Detecting functional modules in the yeast protein-protein interaction network , 2006, Bioinform..

[32]  J. Bartek,et al.  Structure meets function--centrosomes, genome maintenance and the DNA damage response. , 2006, Experimental cell research.

[33]  Yan Zhang,et al.  CanPredict: a computational tool for predicting cancer-associated missense mutations , 2007, Nucleic Acids Res..

[34]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[35]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[36]  Y. Hu,et al.  PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion , 2007, Oncogene.

[37]  J. Reis-Filho,et al.  Molecular Alterations of KIT Oncogene in Gliomas , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[38]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[39]  P. Kleihues,et al.  Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.

[40]  Jianzhi Zhang,et al.  In Search of the Biological Significance of Modular Structures in Protein Networks , 2007, PLoS Comput. Biol..

[41]  Katherine Holmes,et al.  Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. , 2007, Cellular signalling.

[42]  Dirk Walther,et al.  The integrated analysis of metabolic and protein interaction networks reveals novel molecular organizing principles , 2008, BMC Syst. Biol..

[43]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[44]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[45]  G. Parmigiani,et al.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers , 2008, Proceedings of the National Academy of Sciences.

[46]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[47]  P. Kovanen,et al.  KIT overexpression induces proliferation in astrocytes in an imatinib‐responsive manner and associates with proliferation index in gliomas , 2008, International journal of cancer.

[48]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[49]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.

[50]  V. Velculescu Defining the blueprint of the cancer genome. , 2008, Carcinogenesis.

[51]  C. Sander,et al.  Functional Copy-Number Alterations in Cancer , 2008, PloS one.

[52]  N. Schork,et al.  Identification of rare cancer driver mutations by network reconstruction. , 2009, Genome research.

[53]  K. Alitalo,et al.  Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment. , 2009, Cancer research.

[54]  M. Stratton,et al.  The cancer genome , 2009, Nature.

[55]  P. Aloy,et al.  A network medicine approach to human disease , 2009, FEBS letters.